North Bud Farms, through its wholly owned subsidiary GrowPros MMP Inc., which was acquired in February, 2018, is pursuing a licence under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of agricultural land in Low, Que. North Bud Farms will be focused on pharmaceutical- and food-grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October, 2019.
2. Forward Looking Statements
This presentation contains certain forward-looking statements that may involve a number of risks and uncertainties. Actual events or
results could differ materially from the expectations and projections of North Bud Farms Inc. The information contained in this
presentation has not been approved or disapproved by any Securities Commission in Canada, the Securities and Exchange Commission
in the US or other regulatory body. Except for statements of historical fact relating to the Company, certain information contained
herein constitutes "forward-looking statements".
Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate"
and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on
the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties
and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
These factors include the inherent risks involved in making investments in the cannabis industry and associated ancillary businesses
regulated by Canadian federal and provincial governmental agencies, American federal and state governmental agencies or other
international regulatory agencies, the uncertainties involved in the cannabis industry and complexities and timelines associated with
product or service approvals in multiple jurisdictions.
The possibility of project cost overruns or unanticipated costs and expenses, uncertainties relating to the availability and costs of
financing needed in the future and other factors. Circumstances or management's estimates or opinions could change. The reader is
cautioned not to place undue reliance on forward-looking statements. Except as required by law, we undertake no obligation to update
or revise publicly any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on
which the statements are made or to reflect the occurrence of unanticipated events. Neither we nor any of our representatives make
any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this
presentation.
Neither we nor any of our representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any
person resulting from the use of the information in this presentation by you or any of your representatives or from omissions from the
information in this presentation.
3. 3
Company Snapshot:
Founded: 2017
CSE: NBUD CAD$0.25
OTCQB: NOBDF USD$0.19
Market Cap: CAD$16 Million
Shares Issued: 63.4 Million
Shares Fully Diluted: 85.0 Million
Insider Ownership: ~20%
Cash Equivalent: ~$1 Million
6. 6
Strategy:
1. Control cultivation and manufacturing
licenses in each target market
2. Use cultivation and manufacturing efficiencies
to ensure strategic product pricing to gain
market share and drive revenue
8. PURPOSE BUILT FACILITY
24,500 ft2
Indoor Facility:
Estimated: 1,000 kg/year
@ $4/g = $4 Million
800,000 ft2
of Outdoor:
Estimated: 13,500 kg/year
@ $1/g = $13.5 Million
Low cost production with estimated 2020
revenue potential of $17.5M per annum
9. 9
#1 CULTIVATION LICENCE:
*Expandable footprint to 300,000 ft2
#2 MANUFACTURING LICENCE:
Non-Volatile Solvent Extraction
Requires equipment and operators
#3 DISTRIBUTION LICENCE:
Actively pursuing 3rd party distributor
to leverage licence and generate cash
2018 Revenue (unaudited) of USD$4.5M
10. 10
#1 CULTIVATION:
5,000 ft2
licenced indoor canopy
*Approved expansion plans for
50,000 ft2
greenhouse
#2 MANUFACTURING LICENCE:
CO2 Extraction
Industrial kitchen
#3 DISTRIBUTION LICENCE:
Actively pursuing 3rd party
distributor to leverage licence
NEVADA BRANDS
Nevada (USD$7M NBS ACQUISITION)
13. Brendan
Stutt,
CPA CA
CFO
COO at Northbud Capital,
investment firm focused on
early stage cannabis companies
throughout Canada and the U.S.
3 years of cannabis industry
investment analysis and
business development
throughout Canada, the U.S. and
beyond
Built and sold a financial
planning business as a Certified
Financial Planner. BCom
Finance major, completed
various other finance courses
and certifications
Pete
Souchen
Co Founder &
Corporate
Development
Management Team
Justin
Braune, MBA
President of
Bonfire USA
Past President of Made By
Science, Los Angeles based
nanoencapsulation firm
acquired by Acreage Holdings
in a $160 Million acquisition.
Past President of MJIC,
focused on cannabis industry
acquisitions and operations of
which the most successful is
www.rollingpaperdepot.com
US Naval Academy Electrical
& Nuclear Engineer with an
MBA from University of
Southern California, licenced
California real estate broker
Ryan
Brown
Co Founder
& CEO
CEO of Northbud Capital,
investment firm focused on
early stage cannabis companies
throughout Canada and the U.S.
Co-Founder of Tetra Bio Pharma
TSXV: TBP
Board Member for SVG
licenced cannabis producer
Acres Agricultural
Extensive experience in the
importation and distribution of
cultivation equipment and
nutrients
Chartered Professional
Accountant (CPA, CA)
Graduate of Queen's
University and McGill
University
Over a decade of
experience as
corporate controller for
multiple publicly traded
companies
Edward
Miller,
VP Investor
Relations
Eighteen years experience
Biotech/Pharma and
cannabis industries
Corporate branding and
investor outreach for
Tetra-Bio Pharma,
bringing them public
Past-President QC
Chapter-Canadian
Investor Relations
Institute
14. Michael Saxon
Director
Leona Aglukkaq
Director
Member of Parliament,
Nunavut (2008-2015)
Government of Canada,
Minister of Health (2008
-2013)
Government of Canada,
Minister of the Environment
(2013 - 2015)
Chair of Arctic Council
(2013-2015)
CEO, SXN Strategy
Partners
Former executive at Altria
and Philip Morris Int’l,
leading business units on 3
continents
Investment committee
member at Trolley
Ventures
Board member on 2
private companies
Board of Directors
Teresa DeLuca, MD, MBA
Compensation Committee Chair
New York Board-certified in
psychopharmacology
Clinical professor of
Psychiatry, Mt. Sinai College,
NY
Chief Medical Officer,
Magellan
VP, Clinical Sales
Walgreen Co.
Ryan Brown
CEO & Director
André Audet
President & Chairman
Co-Founder & former
Chairman of the Board for
Tetra Bio Pharma (TSXV: TBP)
Founder and CEO of Molecule,
a beverage focused cannabis
manufacturing licence
applicant
Held CEO & Director positions
for multiple publicly listed
companies
Over 25 years of financing
public companies
CEO of Northbud Capital,
investment firm focused on
early stage cannabis companies
throughout Canada and the U.S.
Co-Founder of Tetra Bio Pharma
TSXV: TBP
Board Member for SVG
licenced cannabis producer
Acres Agricultural
Extensive experience in the
importation and distribution of
cultivation equipment and
nutrients
15.
16. North Bud Farms Inc.
Public Parent Co.
$NBUD
Bonfire Brands
Canada Inc.
Bonfire Brands
USA Inc.
(Nevada)
Quebec
Infrastructure
Co.
GrowPros MMP
- Canada Op.
Co.
IP Licensing
Co
Nevada
Op. Co.
Planned Org Chart :
AcquisitionsTo CreateExisting Co.
California
Op. Co.
Licence Agreement Licence Agreement
Licence Agreement
100%
100%
100%
Management Services Agreement
Management Services AgreementManagement Services Agreement
17. Ryan Brown, CEO
+1 (613) 983-6995
ryan@northbud.com
Edward Miller, VP Investor Relations
+1 (855) 628-3420 ext. 3
edward@northbud.com